AOD-9604 vs Orforglipron

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

AOD-9604 and Orforglipron are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares AOD-9604 and Orforglipron across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

AOD-9604Orforglipron
CategoryWeight Management & MetabolicWeight Management & Metabolic
Regulatory status (US)Research use onlyFDA approved
Typical dosage300 mcgClinical trials
Frequencydailydaily
Reported benefitsFat metabolism, body composition improvement, no impact on blood sugar, cartilage repairOral administration convenience, weight loss, glucose control
Reported side effectsMinimal side effects reportedUnder investigation

Key differences

Primary use. AOD-9604 is categorised under Weight Management & Metabolic, while Orforglipron falls under Weight Management & Metabolic. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. AOD-9604: not FDA-approved; treated as a research compound. Orforglipron: FDA-approved.

Dosing. AOD-9604 is typically dosed at 300 mcg (daily). Orforglipron is typically dosed at Clinical trials (daily).

Can you stack them?

Some protocols combine peptides, but stacking AOD-9604 and Orforglipron has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between AOD-9604 and Orforglipron?
AOD-9604 and Orforglipron are both weight management & metabolic peptides, but they differ in mechanism, dosing, and regulatory status. AOD-9604 is not FDA-approved; generally classified as a research compound, whereas Orforglipron is FDA-approved for one or more indications.
What is AOD-9604 used for?
Fat loss, metabolic enhancement.
What is Orforglipron used for?
Oral GLP-1.
Can you take AOD-9604 and Orforglipron together?
Some users combine peptides within a single protocol, but stacking AOD-9604 and Orforglipron has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is AOD-9604 or Orforglipron FDA-approved?
AOD-9604 is not FDA-approved; generally classified as a research compound. Orforglipron is FDA-approved for one or more indications.

Read the full articles

  • AOD-9604 — full monograph: mechanism, research, dosing & references
  • Orforglipron — full monograph: mechanism, research, dosing & references

More Weight Management & Metabolic comparisons

← All peptide comparisons